Lioness Associates, Inc.

Economic & Corporate Risk/Yield Reports

January 18, 2014  -- Alnylam Pharmaceuticals Risk/Yield for 2014

More action to come - Overall, the graphs indicate that this company will have positive activity during the first part of the year.  This is one to watch for additional deals that might be coming to the table.
Refer to
Reading Graphs for information on interpretation of the graphs.  Also, refer to the Global, USA, and other company's graphs on this site for 2013 and compare to market prices for 2013.  Questions .... you can always send an email to


Disclosure as of 1/18/2014 - Alnylam Pharmaceuticals (ALNY) is not part of our portfolio at this time.